Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -43.78% is in line with its 5-year average of -44.93%, around the middle of its 5-year range (-122.70%–-0.09%).
40.28% above its 12-month average of -73.31%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -122.70%.
OPERATING MARGIN
-43.78%
OPERATING MARGIN AVG TTM
-73.31%
OPERATING MARGIN AVG 3Y
-55.29%
OPERATING MARGIN AVG 5Y
-44.93%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+40.28%
CURRENT VS 3Y AVG
+20.82%
CURRENT VS 5Y AVG
+2.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Spectral AI, Inc.
Market Cap
$52.83M
Operating Margin
-43.78%
TTM Avg
-73.31%
3Y Avg
-55.29%
5Y Avg
-44.93%
Market Cap
$52.60M
Operating Margin
-58.66%
TTM Avg
-24.92%
3Y Avg
-0.82%
5Y Avg
4.23%
Market Cap
$51.99M
Operating Margin
N/A
TTM Avg
-19.41%
3Y Avg
-9.70%
5Y Avg
-6.47%
Market Cap
$53.70M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.88M
Operating Margin
-6056.37%
TTM Avg
-3556.76%
3Y Avg
-2097.71%
5Y Avg
-1497.54%
Market Cap
$54.14M
Operating Margin
-2345.99%
TTM Avg
-3766.09%
3Y Avg
-1883.04%
5Y Avg
-2168.71%
Market Cap
$51.19M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$51.12M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Spectral AI, Inc. (MDAI) | $52.83M | -43.78% | -73.31% | -55.29% | -44.93% |
| Zhengye Biotechnology Holding Limited (ZYBT)vs › | $52.60M | -58.66% | -24.92% | -0.82% | 4.23% |
| Eloxx Pharmaceuticals, Inc. (ELOX)vs › | $51.99M | N/A | -19.41% | -9.70% | -6.47% |
| NOMAD Power Solutions, Inc. (NMAD)vs › | $53.70M | 0.00% | 0.00% | 0.00% | 0.00% |
| ImageneBio Inc (IMA)vs › | $51.88M | -6056.37% | -3556.76% | -2097.71% | -1497.54% |
| Rani Therapeutics Holdings, Inc. (RANI)vs › | $54.14M | -2345.99% | -3766.09% | -1883.04% | -2168.71% |
| eXoZymes, Inc. (EXOZ)vs › | $51.23M | 0.00% | 0.00% | 0.00% | 0.00% |
| Tenax Therapeutics, Inc. (TENX)vs › | $51.19M | 0.00% | 0.00% | 0.00% | 0.00% |
| Dogwood Therapeutics, Inc. (DWTX)vs › | $51.12M | 0.00% | 0.00% | 0.00% | 0.00% |
| Aldeyra The (ALDX)vs › | $55.25M | 0.00% | 0.00% | 0.00% | 0.00% |
Gross Margin
41.5%
Operating Margin
-43.8%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -122.70% |
| 2026-03-31 | -49.39% |
| 2025-12-31 | -64.46% |
| 2025-09-30 | -88.11% |
| 2025-06-30 | -41.92% |
| 2025-03-31 | -13.36% |
| 2024-12-31 | -14.61% |
| 2024-09-30 | -10.84% |
| 2024-06-30 | -32.66% |
| 2024-03-31 | -33.88% |
| 2023-12-31 | -55.40% |
| 2023-09-30 | -121.10% |
| 2023-06-30 | -70.36% |
| 2023-03-31 | -57.07% |
| 2022-12-31 | -29.02% |
| 2022-09-30 | -3.57% |
| 2022-06-30 | -0.09% |
| 2022-03-31 | -10.63% |
| 2021-12-31 | -39.74% |
| 2021-09-30 | -39.74% |
